ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

MTEM Molecular Templates Inc

1,28
-0,12 (-8,57%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Molecular Templates Inc MTEM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,12 -8,57% 1,28 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,34 1,25 1,40 1,305 1,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.6.202414:13EDGAR2Form 8-K - Current report
03.6.202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15.5.202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15.5.202423:18EDGAR2Form 8-K - Current report
15.5.202423:11GLOBEMolecular Templates, Inc. Reports First Quarter 2024..
09.4.202414:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29.3.202413:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28.3.202413:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04.3.202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15.2.202402:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202423:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
25.1.202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:04EDGAR2Form 8-K - Current report
13.11.202322:13EDGAR2Form 8-K - Current report
13.11.202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
02.11.202321:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
01.11.202321:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202321:12GLOBEMolecular Templates to Participate in Upcoming Investor..
31.10.202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.10.202322:12EDGAR2Form 8-K - Current report
06.10.202323:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
28.9.202323:01EDGAR2Form 8-K - Current report
28.9.202322:11GLOBEMolecular Templates Announces the Appointment of Dr...
12.9.202323:15EDGAR2Form ARS - Annual Report to Security Holders
12.9.202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12.9.202323:08EDGAR2Form DEF 14A - Other definitive proxy statements
01.9.202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.8.202322:11EDGAR2Form 8-K - Current report
11.8.202322:12EDGAR2Form 8-K - Current report
11.8.202317:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
10.8.202315:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10.8.202314:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:09EDGAR2Form 8-K - Current report
10.8.202314:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
02.8.202322:16EDGAR2Form 8-K - Current report
02.8.202322:11GLOBEMolecular Templates Announces Executive Leadership Changes
18.7.202317:56EDGAR2Form DEF 14A - Other definitive proxy statements
13.7.202318:48EDGAR2Form 8-K - Current report
13.7.202314:14GLOBEMolecular Templates Announces Up to $40 Million Private..
30.6.202322:31EDGAR2Form PRE 14A - Other preliminary proxy statements
17.6.202302:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring

Kürzlich von Ihnen besucht

Delayed Upgrade Clock